Implant Sciences Announces Shipment of Additional $1.2M
WILMINGTON, Mass., July 15, 2015 /PRNewswire/ — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped an additional approximately $1.2 million of its explosives trace detectors to customers around the world.
The sales were comprised of both its QS-B220 desktop explosives and drugs trace detector and its QS-H150 handheld explosives trace detector. These systems were sold across four continents to be deployed in a variety of applications including mass transportation, cargo screening, infrastructure protection, and aviation security.
“As we have executed upon the flurry of ETD sales opportunities in the European Union, we have not relented in our market penetration in other parts of the world,” stated Dr. Darryl Jones, Implant Sciences’ Vice President of Global Sales and Marketing. “The demand for our next generation technology continues to grow globally for numerous applications, and as an ETD market leader in both technology and sales, we are gratified and fully prepared to support this demand.”
“We continue to win additional orders, fueled by our wins from the TSA and internationals airports across the EU. Our ability to successfully build and ship these additional units to other customers is due to our ramped up manufacturing capacity, which enables us to execute on more orders than ever before,” added Dr. Bill McGann, Implant Sciences’ CEO.testtest is test